🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The proposed study V72P9E1 is an Extension Study of V72P9. The objectives o...
Status
Completed
Location
Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Start Date
2010-02
Trial ID
NCT01026974
Treatments Being Tested
The primary objective of this study is to demonstrate the equivalence of rM...
Status
Completed
Location
Royal Children's Hospital
Start Date
2011-08
Trial ID
NCT01423084
Treatments Being Tested
The proposed study is aimed to assess the antibody response and short-term ...
Status
Completed
Location
Site 13: Liceo Diego Aracena de Lo Barnechea
Start Date
2008-06
Trial ID
NCT00661713
Treatments Being Tested
One year antibody persistence after the fourth dose boost or two catch-up d...
Status
Completed
Location
amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec
Start Date
2010-06
Trial ID
NCT01139021
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this study is to assess the safety and immune responses of r...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2023-11-10
Trial ID
NCT06113198
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00297817
The purpose of this trial is to assess the safety of a Meningococcal Group ...
Status
Completed
Location
01, Novartis Investigational Site
Start Date
2014-12
Trial ID
NCT02305446
Treatments Being Tested